STAT
MARCH 11, 2024
UnitedHealth Group quietly acquired dozens of outpatient facilities in 2023, with a particular focus on surgery centers, according to a STAT review of company financial filings. Those acquisitions — nearly all of which the company never announced — build on the network of some 90,000 physicians UnitedHealth Group has amassed in recent years.
ALiEM - Pharm Pearls
MARCH 11, 2024
In July 2022, a 32-year-old male with a past medical history of HIV (on antiretroviral therapy, CD4 390, viral load undetectable) presented to the emergency department with constitutional symptoms and a rash for 4-5 days. His symptoms included malaise, body aches, subjective fevers, a sore throat, tender, swollen neck glands, body rash, and irritation of his left eye.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
STAT
MARCH 11, 2024
Despite being the largest minority in the nation , disabled people like us have been structurally and institutionally obstructed from entering research-dominated fields. When they do manage to break through, they are seldom given the support and accommodations needed to sustain employment and thrive in their professional lives. As we have experienced, including people with disabilities in academic leadership and decision-making positions can lead to innovation, creative problem-solving, and insi
PharmaVoice
MARCH 11, 2024
One rare disease survivor’s diagnosis experience highlights the need for pharma companies to better understand the patient journey.
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
STAT
MARCH 11, 2024
Every year, Lisa Campo-Engelstein tells her medical ethics class the story of Isabel: A fictional character who arrives at a health clinic seeking an abortion. Doctors determine that Isabel is 37 weeks pregnant and, what’s more, she’s suffering from high blood pressure that endangers the life of the fetus. Thirty-seven weeks is just three shy of an average full-length pregnancy, so instead of an abortion, the clinic’s doctors recommend that Isabel have an emergency C-section
PharmaVoice
MARCH 11, 2024
With COVID-19 vaccine sales dying down, Pfizer and Moderna turn to growth in different ways to cement their status as mRNA leaders.
Pharmacist Digest brings together the best content for pharmacists from the widest variety of industry thought leaders.
BioPharma Dive
MARCH 11, 2024
Publicly traded companies raised nearly $10 billion in follow-on stock offerings in January and February, a financing surge that’s driving a “sector recovery,” the investment bank said.
STAT
MARCH 11, 2024
Hundreds of messages from an internal chat board for an international group of transgender health professionals were leaked in a think tank report last week and framed as revealing serious health risks associated with gender-affirming care, including cancer. But experts say this correlation is false and oversimplifies the complex role of hormones in the body.
Outsourcing Pharma
MARCH 11, 2024
On March 7, Celadon Pharmaceuticals plc, a leading UK-based pharmaceutical company specializing in cannabis-based medicines, unveiled promising findings from an early economic analysis of its chronic pain clinical trial, dubbed CANPAIN.
STAT
MARCH 11, 2024
Acadia Pharmaceuticals said Monday that its approved medicine called Nuplazid failed to improve the social and emotional symptoms of schizophrenia in a late-stage clinical trial. The negative outcome of the Phase 3 study represents a setback in the company’s efforts to expand the use of Nuplazid into the treatment of schizophrenia. The medicine is currently approved to treat hallucinations and delusions associated with Parkinson’s disease psychosis.
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
PharmaVoice
MARCH 11, 2024
The Blackstone Life Sciences-backed company plans to focus on later-stage assets to help derisk development.
STAT
MARCH 11, 2024
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Today, we talk about a new online marketplace to trade animal parts for research, an initiative to ensure ethics in AI-driven protein synthesis, and more.
BioPharma Dive
MARCH 11, 2024
Justin Klee and Joshua Cohen spoke to BioPharma Dive about the next steps for their company, which is considering pulling its only product from market after the drug failed a confirmatory study in ALS.
STAT
MARCH 11, 2024
Good morning, everyone, and welcome to another working week. We hope the weekend respite was relaxing and invigorating, because that oh-so familiar routine of online meetings, calls, and deadlines has predictably returned. But what can you do? The world, such as it is, continues to spin. So time to give it a nudge in a better direction with a cup of stimulation.
Pharmaceutical Technology
MARCH 11, 2024
Upcoming regulatory events for pipeline AAV gene therapies, with a focus on neuromuscular and blood disorders, are setting high expectations for the space in 2024.
pharmaphorum
MARCH 11, 2024
Shares in Amylyx have cratered after the company reported a confirmatory trial of its amyotrophic lateral sclerosis (ALS) therapy Relyvrio missed all its objectives, putting its accelerated approval in jeopardy.
Express Pharma
MARCH 11, 2024
The upcoming Pharma Industry Townhall by PharmaState Academy offers an array of insightful talks, panel discussions, and presentations. The details are as follows: Event Date: March 16, 2024 Location: Radisson Blu Marol Andheri Time: 09:00 AM – 05:00 PM The event aims to equip professionals with the latest knowledge and strategies crucial for navigating the industry’s changing dynamics.
BioPharma Dive
MARCH 11, 2024
Sosei Heptares could receive more than 700 million euros in a deal to develop medicines aimed at the protein GPR52, an emerging drug target in multiple neurological diseases.
pharmaphorum
MARCH 11, 2024
Enhancing clinical trial outcomes through algorithmic prespecification in subgroup analysis can provide valuable insights for the FDA and medical community. Learn more about this practice and its importance in clinical research.
BioPharma Dive
MARCH 11, 2024
Roche said its experimental Alzheimer’s disease drug trontinemab showed it might be able to clear brain plaques faster than other medicines.
pharmaphorum
MARCH 11, 2024
Novo Nordisk’s Wegovy has been given a first-in-class approval by the FDA to reduce the risk of serious cardiovascular conditions in people who are overweight or obese
BioPharma Dive
MARCH 11, 2024
Innovative technologies, such as flow chemistry and biocatalysis, are achieving not only sustainability goals but also unprecedented levels of quality and efficiency.
Express Pharma
MARCH 11, 2024
Control Print, integrated coding and marking solutions provider, announced the acquisition of a majority stake in Codeology Group, a UK-based provider of print and apply systems. As a part of the deal, Control Print has acquired 50.49 per cent of the stake in the company for £ 1 million. Control Print plans to use Codeology’s Print and Apply systems in the Indian market in the next three months.
pharmaphorum
MARCH 11, 2024
Stay updated with the latest pharma and biotech hires from February 2024 at companies like AbbVie, Astellas, EnteroBiotix, and Resalis Therapeutics in Changing Faces.
The Pharmacist
MARCH 11, 2024
Almost half of adults aged over 40 are unaware they can have a free blood pressure check at a community pharmacy, a survey commissioned by NHS England has suggested. The finding comes as part of a new national campaign launched today to find the ‘missing millions’ who have undiagnosed high blood pressure and to encourage […] The post ‘Too many’ unaware of pharmacy blood pressure checks appeared first on The Pharmacist.
European Pharmaceutical Review
MARCH 11, 2024
Since the HIV epidemic began in the early 1980s, more than 85 million people have been diagnosed worldwide and about 40 million have died as a result of complications from the virus. 1 Now, four decades later, 39 million people around the world are living with HIV, primarily due to advances in treatment. 1 With continued innovation on the horizon in terms of prevention and treatment methods, what was once a wishful hope of ending the epidemic has become a conceivable goal.
pharmaphorum
MARCH 11, 2024
Learn about the warning signs for potential secondary cancer cases related to CAR-T therapies. Understand the risks associated with cytokine release syndrome and other side effects of CAR-T treatment.
Pharmafile
MARCH 11, 2024
Aspire Pharma has announced that it has successfully acquired Cenoté Pharma as part of its plan to supplement its growth using various acquisitions and strategic partnerships. This acquisition marks the fourth that Aspire Pharma has undertaken since it was acquired by an affiliate of HIG Capital in 2021. It is intended to strengthen the company’s […] The post Aspire Pharma acquires Cenoté Pharma appeared first on Pharmafile.
pharmaphorum
MARCH 11, 2024
Stay updated on the latest developments in clinical trials with highlights from Medigene, Artax, and KalVista from 12th to 16th February 2024.
Express Pharma
MARCH 11, 2024
Venus Remedies has recently secured Good Manufacturing Practices (GMP) approval from the United Nations International Children’s Emergency Fund (UNICEF). Venus Remedies’ manufacturing unit, located in Baddi, Himachal Pradesh, India, has been recommended for supplying cephalosporin dry powder, a class of β-lactam antibiotic for treating bacterial infections, to UNICEF. hains.
pharmaphorum
MARCH 11, 2024
Boehringer Ingelheim has taken an option on a family of GPR52 agonist compounds with potential in schizophrenia from Sosei Heptares, in a €755m deal
Outsourcing Pharma
MARCH 11, 2024
A conversation between Colin Weller, VP and GM of the evidence platform at Medable and Liza Laws, senior editor, at Outsourcing Pharma, was held at this yearâs SCOPE 2024 in Orlando.
European Pharmaceutical Review
MARCH 11, 2024
In a review on fungal-contaminated compounded pharmaceuticals and medical devices, researchers have described how the contamination of these products can be due to breaches in sterile compounding procedures. The authors explained: “inadequate sterile compounding techniques or storage conditions, or exceeding the limit of a fungal count, can result in fungal contamination.
BioPharma Dive
MARCH 11, 2024
SDoH data can help companies understand the footprint of weight loss medications in the market and their impact across populations.
pharmaphorum
MARCH 11, 2024
J&J says oral IL-23 inhibitor JNJ-2113 shows a durable effect in psoriasis, making it a potential companion to its injectable Tremfya.
Expert insights. Personalized for you.
362 
Let's personalize your content